JHIU
STJ

Janus Henderson Investors US’s St Jude Medical STJ Stock Holding History

Janus Henderson Investors US’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-253,557
Closed -$20.3M – 1244
2016
Q4 		$20.3M Buy
253,557
+217,564
+604% +$17.3M 0.02% 611
2016
Q3 		$2.87M Sell
35,993
-2,549
-7% -$206K ﹤0.01% 901
2016
Q2 		$3.01M Sell
38,542
-2,292,641
-98% -$163M ﹤0.01% 846
2016
Q1 		$128M Buy
2,331,183
+2,254,866
+2,955% +$123M 0.11% 241
2015
Q4 		$4.71M Sell
76,317
-51,600
-40% -$3.25M ﹤0.01% 831
2015
Q3 		$8.07M Buy
127,917
+7,602
+6% +$543K 0.01% 751
2015
Q2 		$8.79M Sell
120,315
-258,477
-68% -$18.7M 0.01% 715
2015
Q1 		$24.8M Sell
378,792
-1,432,127
-79% -$95.2M 0.02% 580
2014
Q4 		$118M Sell
1,810,919
-1,492,479
-45% -$96.1M 0.1% 263
2014
Q3 		$199M Buy
3,303,398
+290,516
+10% +$19M 0.18% 152
2014
Q2 		$209M Buy
3,012,882
+461,902
+18% +$29.9M 0.19% 149
2014
Q1 		$167M Buy
2,550,980
+1,434,814
+129% +$93.4M 0.16% 177
2013
Q4 		$69.1M Sell
1,116,166
-236,499
-17% -$13.7M 0.07% 331
2013
Q3 		$72.6M Sell
1,352,665
-559,003
-29% -$28.8M 0.07% 299
2013
Q2 		$87.2M Buy
+1,911,668
New +$82.8M 0.09% 259

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Janus Henderson Investors US's STJ Position: Q1 2017 in Review

Janus Henderson Investors US sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 253,557 shares — an estimated $20.3M sold.

Janus Henderson Investors US first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $209M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Janus Henderson Investors US reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Janus Henderson Investors US sold 253,557 St Jude Medical shares in Q1 2017, an estimated $20.3M.
  • Janus Henderson Investors US first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Janus Henderson Investors US's St Jude Medical position peaked at $209M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.